Contributors
Howie Sim
Senior Partner of Healthcare & Transport, NCS
Howie leads the Client Service Unit for Healthcare & Transport in NCS. He is focused on helping healthcare and transport organisations digitally transform their services to become more people-centric and to support the future demands in smart cities
James Raussen
Management consultant in Southeast Asia with more than 20 years experience in the healthcare industry, public policy, and business to business development. He currently lives in Vietnam and can be reached on LinkedIn.
John Young
Principal in Heidrick & Struggles’ Singapore office and a member of the global Technology & Services Practice
Joshua Siow
Joshua is a Director in the Life Sciences division of Simon-Kucher & Partners, with a focus on healthcare in Asia.
At Simon-Kucher & Partners, Joshua is a specialist in the pharmaceutical industry, and provides expert advice on a variety of topline topics including:
- Market sizing, segmentation, and prioritization
- Value-based pricing and price optimization
- Market access and reimbursement strategies
- Value communication and marketing strategies
- Global pricing policy guidance and development
- International Price Referencing and launch sequence optimization
Julian Hong
Dr Julian Hong is Head at Thomson Specialists (Woodleigh), the first integrated ambulatory surgical centre in Singapore. In his role also as Director, Operations & Special Projects, he builds and runs patient-centric integrated ambulatory centres and also develops value-based clinical programmes that intersect clinical and commercial excellence.
Before joining Thomson Medical, Dr Hong headed Executive Health Screening with Radiology, Primary Care Clinics, with responsibilities in business development, strategy, marketing and operations in various listed healthcare companies, achieving excellent financial outcomes.
As a healthcare leader, he has a decade of experience in ambulatory care, management and digital health (electronic medical records, e-commerce, monitoring devices, AI, data protection, telemedicine and digital transformation).
In his medical training years, Dr Hong contributed to medical research, winning research grants, prizes and awards along the way. He applies the same curiosity to the healthcare investments space, keeping abreast of the latest medical advances, and has served as medical director and medical advisor to various health-tech companies.
Dr Hong subscribes to the ethos of "healing" outside the walls of the hospital and is an active community volunteer, catalysing 3P partnerships. He has also served on the board of charities supporting caregivers and mental health.
Dr Hong graduated from the Imperial College School of Medicine in London with a Bachelor of Medicine and Bachelor of Surgery (MBBS). He is due to complete his Executive Master of Business Administration (EMBA) from the National University of Singapore (NUS) and has a Diploma in Biotechnology from Ngee Ann Polytechnic Singapore.
Commentary
Beyond ChatGPT: The rise of multimodal AI assistants in clinical settings
2026 biotech playbook: Hong Kong at the centre of China’s globalisation